# A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

> clinical trial · VERIFIED · 2026-08-18

Status: ACTIVE_NOT_RECRUITING · Sponsor: Shanghai Henlius Biotech · Condition: Non-small Cell Lung Cancer

- Company: Shanghai Henlius Biotech
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07160335

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.